Senior Director, Medical Affairs at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

MD, DO, NP, PA, PharmD, or other advanced health care degree with 8+ years of relevant industry/clinical experience in HIV
At least 5 years of Pharma industry experience, with leadership roles preferred
Excellent verbal, written, visual communication, and interpersonal skills
Experience in vendor contracting and preparing budgets
Must be fully cognizant and adhere to regulatory and legal (Business Conduct) requirements for US Medical Affairs activities

Responsibilities

Acts as a scientific expert medical liaison to foster alignment and collaboration between US Medical Affairs, Global Medical Affairs, and US/Global Commercial teams
Serve as the medical and scientific expert for the HIV portfolio, supporting the commercial strategy and marketing teams
Provide strategic medical input into brand planning, lifecycle management, and commercialization efforts
Represent Medical Affairs in commercialization team meetings, ensuring alignment of medical and commercial strategies
Communicate medical initiatives, strategies, data timelines, and publication plans to commercial stakeholders
Collaborate with Legal, Regulatory, Clinical, Public/Government Affairs, and other partner functions to lead or support cross-functional projects
Provide medical support for US commercial activities including but not limited to Scientific advisory boards (planning, content review, and presentation)
Promotional Review Committee (PRC) concept discussions and material reviews
Ensure medical narrative alignment and scientific accuracy in commercial materials and campaigns
Review and contribute to commercial training materials for sales and clinical liaison teams
Present at commercial training sessions, including midyear and national meetings
Support the development and delivery of training workshops and strategic/tactical planning sessions
Support the US Strategy Lead in portfolio management and launch planning activities
Align medical initiatives and POA tactical planning with the local strategic cross-functional plan

Skills

Medical Affairs

HIV Treatment

Strategic Medical Leadership

Scientific Expertise

Medical Liaison

Cross-functional Collaboration

Brand Strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free